Answers are grounded in this paper and cite their sources.
Evaluates efficacy and safety of inebilizumab in generalized myasthenia gravis, suggesting benefits in treatment.
To evaluate the real-world efficacy and safety of inebilizumab in patients with generalized myasthenia gravis (gMG).
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: